On this page
Jay Saoud
Insider
First SEC filing: Dec. 15, 2017 · Latest: Dec. 15, 2017
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Oct. 13, 2020 | NERV | A | 100,000 | · | · | 100,000 Direct | · | Acquired | (price as of 2026-10-02) |
| June 19, 2020 | NERV | A | 236,202 | · | · | 236,202 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 31, 2019 | NERV | A | 63,798 | · | · | 63,798 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 11, 2018 | NERV | A | 96,000 | · | · | 96,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 13, 2017 | NERV | A | 175,000 | · | · | 175,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Sept. 1, 2017 | NERV | A | 100,000 | · | · | 100,000 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Oct. 13, 2020 | NERV | Employee Stock Option (right to buy) | Common Stock | $3.50 | Oct. 12, 2030 | 100,000 | Acquired |
| June 19, 2020 | NERV | Employee Stock Option (right to buy) | Common Stock | $7.11 | Dec. 31, 2029 | 236,202 | Acquired |
| Dec. 31, 2019 | NERV | Employee Stock Option (right to buy) | Common Stock | $7.11 | Dec. 30, 2029 | 63,798 | Acquired |
| Dec. 11, 2018 | NERV | Employee Stock Option (right to buy) | Common Stock | $7.96 | Dec. 10, 2028 | 96,000 | Acquired |
| Dec. 13, 2017 | NERV | Employee Stock Option (Right to Buy) | Common Stock | $6.10 | Dec. 13, 2027 | 175,000 | Acquired |
| Sept. 1, 2017 | NERV | Employee Stock Option (Right to Buy) | Common Stock | $6.45 | Aug. 31, 2017 | 100,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).